feed,title,long_url,short_url
Benzinga,VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China,https://www.benzinga.com/pressreleases/21/01/n19087716/visen-pharmaceuticals-closes-150-million-series-b-financing-to-accelerate-the-development-and-comm,https://j.mp/38qfWG8
